News & Updates
Filter by Specialty:
Going about colorectal screening the COREC way
The MOH and MIMS colorectal screening awareness programme is well under way with the launch of two subsequent education modules. The collaboration is known as “COREC: Battling colorectal cancer together” with the first module launched early 2022.
Going about colorectal screening the COREC way
13 Jul 2022Ozoralizumab shows therapeutic potential in rheumatoid arthritis
Treatment with the next-generation anti-TNFα antibody yields marked improvements in the signs and symptoms of rheumatoid arthritis in patients with inadequate response to methotrexate (MTX), while having an acceptable safety profile, as shown in the phase II/III OHZORA trial.
Ozoralizumab shows therapeutic potential in rheumatoid arthritis
13 Jul 2022More than 6 in 10 hospitalized diabetics have obstructive sleep apnoea
Obstructive sleep apnoea syndrome (OSAS) is common among hospitalized patients with type 2 diabetes mellitus (T2DM), afflicting over 60 percent of this patient population, a recent China study has found.
More than 6 in 10 hospitalized diabetics have obstructive sleep apnoea
12 Jul 2022Ventral striatum connectivity may predict depression in adolescence
The connectivity strength of the ventral striatum (VS) within the reward network demonstrates links to depressive disorders and anhedonia from mid to late adolescence, which indicates the role played by this circuitry in depression changes with age, reveals a study.
Ventral striatum connectivity may predict depression in adolescence
12 Jul 2022Solithromycin safe, effective in paediatric community-acquired bacterial pneumonia
Treatment with intravenous or oral solithromycin is well-tolerated and leads to clinical improvement in most children and adolescents with community-acquired bacterial pneumonia (CABP), results of a recent study have shown.
Solithromycin safe, effective in paediatric community-acquired bacterial pneumonia
12 Jul 2022Can very low-risk breast cancer patients be spared from postop radiotherapy?
Adjuvant radiotherapy (RT) may be omitted in women with very low-risk breast cancer who have had breast conserving surgery (BCS) and have been receiving endocrine therapy, according to findings from the LUMINA study.